Hayden Donald J Jr - Net Worth and Insider Trading
Hayden Donald J Jr Net Worth
The estimated net worth of Hayden Donald J Jr is at least $4 Million dollars as of 2024-11-13. Hayden Donald J Jr is the Director of Insmed Inc and owns about 62,197 shares of Insmed Inc (INSM) stock worth over $4 Million. Hayden Donald J Jr is the Director of Amicus Therapeutics Inc and owns about 5,814 shares of Amicus Therapeutics Inc (FOLD) stock worth over $60,989. Hayden Donald J Jr is also the Director of Theseus Pharmaceuticals Inc and owns about 10,000 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $40,600. Besides these, Hayden Donald J Jr also holds Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) . Details can be seen in Hayden Donald J Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hayden Donald J Jr has not made any transactions after 2022-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hayden Donald J Jr
Hayden Donald J Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hayden Donald J Jr owns 6 companies in total, including Regenxbio Inc (RGNX) , Insmed Inc (INSM) , and Amicus Therapeutics Inc (FOLD) among others .
Click here to see the complete history of Hayden Donald J Jr’s form 4 insider trades.
Insider Ownership Summary of Hayden Donald J Jr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RGNX | Regenxbio Inc | 2020-02-10 | director |
INSM | Insmed Inc | 2019-04-09 | director |
FOLD | Amicus Therapeutics Inc | 2018-01-02 | director |
2016-10-25 | director | ||
2003-09-10 | EVP and President & Americas | ||
2022-12-30 | director |
Hayden Donald J Jr Latest Holdings Summary
Hayden Donald J Jr currently owns a total of 5 stocks. Among these stocks, Hayden Donald J Jr owns 62,197 shares of Insmed Inc (INSM) as of April 9, 2019, with a value of $4 Million and a weighting of 97.72%. Hayden Donald J Jr owns 5,814 shares of Amicus Therapeutics Inc (FOLD) as of January 2, 2018, with a value of $60,989 and a weighting of 1.37%. Hayden Donald J Jr also owns 10,000 shares of Theseus Pharmaceuticals Inc (THRX) as of December 30, 2022, with a value of $40,600 and a weighting of 0.91%. The other 2 stocks Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Hayden Donald J Jr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INSM | Insmed Inc | 2019-04-09 | 62,197 | 70.12 | 4,361,254 |
FOLD | Amicus Therapeutics Inc | 2018-01-02 | 5,814 | 10.49 | 60,989 |
THRX | Theseus Pharmaceuticals Inc | 2022-12-30 | 10,000 | 4.06 | 40,600 |
RGNX | Regenxbio Inc | 2020-02-10 | 0 | 10.49 | 0 |
VTAE | Vitae Pharmaceuticals Inc | 2016-03-21 | 0 | 21.00 | 0 |
Holding Weightings of Hayden Donald J Jr
Hayden Donald J Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Insmed Inc (INSM) over the past 5 years. The most-recent trade in Insmed Inc is the sale of 6,286 shares on April 9, 2019, which brought Hayden Donald J Jr around $207,375.
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 20,000 shares on January 2, 2018, which brought Hayden Donald J Jr around $300,000.
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 1 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 10,000 shares on December 30, 2022, which cost Hayden Donald J Jr around $50,000.
More details on Hayden Donald J Jr's insider transactions can be found in the Insider Trading History of Hayden Donald J Jr table.Insider Trading History of Hayden Donald J Jr
- 1
Hayden Donald J Jr Trading Performance
GuruFocus tracks the stock performance after each of Hayden Donald J Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hayden Donald J Jr is 55.02%. GuruFocus also compares Hayden Donald J Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hayden Donald J Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hayden Donald J Jr's insider trading performs compared to the benchmark.
Performance of Hayden Donald J Jr
Hayden Donald J Jr Ownership Network
Ownership Network List of Hayden Donald J Jr
Ownership Network Relation of Hayden Donald J Jr
Hayden Donald J Jr Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Hayden Donald J Jr is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Hayden Donald J Jr made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Hayden Donald J Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Hayden Donald J Jr. You might contact Hayden Donald J Jr via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.